Anti-Xa activity and hemorrhagic event: isn't it time to consider time ?

Affiliations

¹ Intensive Care Medecine, ICU Department, Hopital Universitaire Des Enfants Reine Fabiola HUDERF, Université Libre de Bruxelles, ULB, Av J.J. Crocq 15, 1020, Brussels, Belgium. Sebastien.redant@huderf.be.
² ICU Department, Centre Hospitalier Universitaire Brugmann - Brugmann University Hospital, Place Van Gehuchtenplein,4, 1020, Brussels, Belgium. Sebastien.redant@huderf.be.
³ Intensive Care Medecine, ICU Department, Hopital Universitaire Des Enfants Reine Fabiola HUDERF, Université Libre de Bruxelles, ULB, Av J.J. Crocq 15, 1020, Brussels, Belgium.
⁴ ICU Department, Centre Hospitalier Universitaire Brugmann - Brugmann University Hospital, Place Van Gehuchtenplein,4, 1020, Brussels, Belgium.

Comment

Sébastien Redant et al. Crit Care. 2021.

. 2021 Jun 14;25(1):210.

doi: 10.1186/s13054-021-03612-7.

¹ Intensive Care Medecine, ICU Department, Hopital Universitaire Des Enfants Reine Fabiola HUDERF, Université Libre de Bruxelles, ULB, Av J.J. Crocq 15, 1020, Brussels, Belgium. Sebastien.redant@huderf.be.
² ICU Department, Centre Hospitalier Universitaire Brugmann - Brugmann University Hospital, Place Van Gehuchtenplein,4, 1020, Brussels, Belgium. Sebastien.redant@huderf.be.
³ Intensive Care Medecine, ICU Department, Hopital Universitaire Des Enfants Reine Fabiola HUDERF, Université Libre de Bruxelles, ULB, Av J.J. Crocq 15, 1020, Brussels, Belgium.
⁴ ICU Department, Centre Hospitalier Universitaire Brugmann - Brugmann University Hospital, Place Van Gehuchtenplein,4, 1020, Brussels, Belgium.

No abstract available

Conflict of interest statement

The authors declare that they have no competing interests.

Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study.
Descamps R, Moussa MD, Besnier E, Fischer MO, Preau S, Tamion F, Daubin C, Cousin N, Vincentelli A, Goutay J, Du Cheyron D. Descamps R, et al. Crit Care. 2021 Apr 2;25(1):127. doi: 10.1186/s13054-021-03554-0. Crit Care. 2021. PMID: 33810800 Free PMC article.

1. Descamps R, Moussa MD, Besnier E, Fischer MO, Preau S, Tamion F, Daubin C, Cousin N, Vincentelli A, Goutay J, Du Cheyron D. Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study. Crit Care. 2021;25(1):127. doi: 10.1186/s13054-021-03554-0. - DOI - PMC - PubMed
1. Protti A, Iapichino GE, Di Nardo M, Panigada M, Gattinoni L. Anticoagulation management and antithrombin supplementation practice during veno-venous extracorporeal membrane oxygenation: a worldwide survey. Anesthesiology. 2020;132(3):562–570. doi: 10.1097/ALN.0000000000003044. - DOI - PubMed
1. Karkouti K, O'Farrell R, Yau TM, Beattie WS, Reducing Bleeding in Cardiac Surgery Research Group Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth. 2006;53(8):781–794. doi: 10.1007/BF03022795. - DOI - PubMed
1. Apichino GE, Protti A, Andreis DT, Panigada M, Artoni A, Novembrino C, Pesenti A, Gattinoni L. Antithrombin during extracorporeal membrane oxygenation in adults: national survey and retrospective analysis. ASAIO J. 2019;65(3):257–263. doi: 10.1097/MAT.0000000000000806. - DOI - PubMed
1. Arnouk S, Altshuler D, Lewis TC, Merchan C, Smith DE, 3rd, Toy B, Zakhary B, Papadopoulos J. Evaluation of anti-Xa and activated partial thromboplastin time monitoring of heparin in adult patients receiving extracorporeal membrane oxygenation support. ASAIO J. 2020;66(3):300–306. doi: 10.1097/MAT.0000000000001004. - DOI - PubMed